AU525005B2 - New peptide derivatives - Google Patents

New peptide derivatives

Info

Publication number
AU525005B2
AU525005B2 AU37230/78A AU3723078A AU525005B2 AU 525005 B2 AU525005 B2 AU 525005B2 AU 37230/78 A AU37230/78 A AU 37230/78A AU 3723078 A AU3723078 A AU 3723078A AU 525005 B2 AU525005 B2 AU 525005B2
Authority
AU
Australia
Prior art keywords
peptide derivatives
new peptide
new
derivatives
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU37230/78A
Other languages
English (en)
Other versions
AU3723078A (en
Inventor
Et Al Lajos Zoltan Barcsay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU3723078A publication Critical patent/AU3723078A/en
Application granted granted Critical
Publication of AU525005B2 publication Critical patent/AU525005B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069—Ser-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU37230/78A 1977-06-20 1978-06-19 New peptide derivatives Expired AU525005B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU77584 1977-06-20
LULU77584 1977-06-20

Publications (2)

Publication Number Publication Date
AU3723078A AU3723078A (en) 1980-01-03
AU525005B2 true AU525005B2 (en) 1982-10-14

Family

ID=19728618

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37230/78A Expired AU525005B2 (en) 1977-06-20 1978-06-19 New peptide derivatives

Country Status (18)

Country Link
EP (1) EP0000330B1 (fr)
JP (2) JPS549224A (fr)
AT (1) AT364095B (fr)
AU (1) AU525005B2 (fr)
CA (1) CA1139305A (fr)
DD (1) DD139257A5 (fr)
DE (1) DE2860893D1 (fr)
DK (1) DK275178A (fr)
ES (3) ES470961A1 (fr)
FI (1) FI781933A (fr)
GR (1) GR71681B (fr)
IE (1) IE46957B1 (fr)
IL (1) IL54950A (fr)
NO (1) NO148921C (fr)
NZ (1) NZ187611A (fr)
PL (3) PL216739A1 (fr)
PT (1) PT68188A (fr)
ZA (1) ZA783504B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014815A3 (fr) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Dérivés peptidiques, procédé pour leur préparation et intermédiaires, et compositions pharmaceutiques contenant un de ces composés
DE3485094D1 (de) * 1983-01-25 1991-10-31 Ciba Geigy Ag Neue peptidderivate.
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
EP0306912A3 (fr) * 1987-09-08 1989-07-05 Albany Medical College Ensemble immunogène capable de provoquer sélectivement la production d'anticorps et compositions pharmaceutiques l'utilisant.
DE4119856A1 (de) * 1991-06-17 1992-12-24 Hoechst Ag N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
ES2096064T3 (es) * 1991-12-19 1997-03-01 Ciba Geigy Ag Derivados del acido aminosulfonico y procedimiento para su obtencion.
AU666789B2 (en) * 1992-12-28 1996-02-22 Takeda Chemical Industries Ltd. 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
EP0604945A1 (fr) 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, dérivés, préparation et utilisation
EP0641776A3 (fr) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Dérivés de thioglycérol.
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
DE10048840A1 (de) * 2000-10-02 2002-04-11 Biotechnolog Forschung Gmbh Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
FR2816060A1 (fr) * 2000-10-27 2002-05-03 Pf Medicament Procede d'identification de nouvelles molecules se liant au recepteur lox et utilisation de ces molecules
EA014644B1 (ru) 2005-06-13 2010-12-30 Кливлэнд Биолабс Инк. Способы защиты от апоптоза с применением липопептидов
EP1909813A4 (fr) * 2005-07-25 2009-09-09 Therimunex Llc Diacylglycerides peptidyle
DE102016005550A1 (de) 2016-05-09 2017-11-09 Emc Microcollections Gmbh Adjuvans zur lnduzierung einer zellulären lmmunantwort
MX2020004742A (es) * 2017-11-06 2020-08-13 Crown Equip Corp Sistema de colocacion lateral de vehiculo industrial.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2706490A1 (de) 1976-02-20 1977-08-25 Ciba Geigy Ag Neue carbonsaeureester

Also Published As

Publication number Publication date
NO148921C (no) 1984-01-11
DE2860893D1 (en) 1981-11-05
FI781933A (fi) 1978-12-21
ZA783504B (en) 1979-06-27
ATA445178A (de) 1981-02-15
GR71681B (fr) 1983-06-21
PL216739A1 (fr) 1980-05-19
NO782138L (no) 1978-12-21
IE46957B1 (en) 1983-11-16
ES470961A1 (es) 1980-03-01
PL216740A1 (fr) 1980-05-19
ES478717A1 (es) 1979-12-16
JPS549224A (en) 1979-01-24
JPS6372671A (ja) 1988-04-02
IL54950A (en) 1983-10-31
IL54950A0 (en) 1978-08-31
CA1139305A (fr) 1983-01-11
PT68188A (de) 1978-07-01
JPS6360760B2 (fr) 1988-11-25
AU3723078A (en) 1980-01-03
EP0000330A1 (fr) 1979-01-24
IE781227L (en) 1978-12-20
PL207766A1 (pl) 1979-11-19
NO148921B (no) 1983-10-03
JPS641466B2 (fr) 1989-01-11
EP0000330B1 (fr) 1981-08-05
ES478718A1 (es) 1979-12-16
NZ187611A (en) 1981-07-13
DD139257A5 (de) 1979-12-19
AT364095B (de) 1981-09-25
DK275178A (da) 1978-12-21

Similar Documents

Publication Publication Date Title
AU518282B2 (en) Amino act d derivatives
AU519122B2 (en) Peptides
AU522716B2 (en) Acylanilide derivatives
AU518216B2 (en) Thienothiazine derivatives
AU3900678A (en) Tripherylalkene derivatives
AU525005B2 (en) New peptide derivatives
AU4208778A (en) Thiohydantion derivatives
AU512266B2 (en) M-trifluoromethylphenylpiperazine derivatives
AU530985B2 (en) Peptides
AU3263178A (en) Ethoxygquin derivatives
AU515458B2 (en) Antioestrogenic phenylbut-1-ene derivatives
AU507066B1 (en) 2-Substituted-5-Hydroxy-1h-Imidazole 4-Carbozamide Derivatives
AU512057B2 (en) Meta-sulfonamido-benzamide derivatives
AU520315B2 (en) Tetrapeptide derivatives
AU515104B2 (en) Oxadiazolopyrimidine derivatives
AU520334B2 (en) 25-alkylcholesterol derivatives
AU519005B2 (en) Phenylacycloakane derivatives
AU521883B2 (en) Pyranochromone derivatives
AU502293B1 (en) 4-amino-oleandomycin derivatives
AU517387B2 (en) Tetracyclononane derivatives
AU516948B2 (en) Fortimicing derivatives
AU519292B2 (en) NEW 3-AMINO-17a azad-HOMOANDROSTONE DERIVATIVES
AU523886B2 (en) Substituted tetrapeptides
AU516891B2 (en) Pregn-4-ene derivatives
AU519815B2 (en) New tetrapeptides